Episode Summary
Executive Summary: The episode demystifies hypnosis as a research-backed clinical tool rather than a stage trick. Dr. David Patterson explains how hypnosis alters attention and brain activity, where it helps most (especially pain, anxiety, IBS, smoking cessation), why it cannot force antisocial behavior, and how to find qualified care. He also discusses self-hypnosis, trauma cautions, remote delivery, and links to mindfulness and psychedelic therapy.
Main Topics: Clinical hypnosis vs. stage hypnosis: Patterson distinguishes therapeutic hypnosis from entertainment, noting stage acts select highly responsive volunteers and rely on performance dynamics, while clinical hypnosis is used to enhance treatment outcomes. Brain and body mechanisms of hypnosis: He describes hypnosis as a sequence of attentional and neural changes, including increased focus, reduced prefrontal judgment, and engagement of suggestion-related brain regions rather than a sleep state. Evidence-based uses in health care: The conversation highlights strongest evidence for acute/chronic pain, burn care, surgery, IBS, anxiety, smoking cessation, and some weight-loss benefits, especially when paired with psychotherapy. Limits, risks, and misconceptions: Patterson emphasizes that hypnosis cannot reliably make people commit crimes or act against core values, but it can create vivid false memories or distress in highly dissociative trauma survivors if used carelessly. Training, self-hypnosis, and clinical delivery: He recommends skilled clinicians who integrate hypnosis into broader therapy, notes that self-hypnosis and recorded inductions can help, and explains that remote hypnosis via Zoom is feasible though less effective than in-person work. Historical burn-care innovation and combined modalities: Patterson recounts using hypnosis in burn debridement and later combining it with immersive virtual reality, though he says hypnosis and VR each work well on their own and are not yet seamlessly fused. Broader mind-body and contemplative framework: He connects hypnosis with mindfulness, meditation, and psychedelic-assisted therapy, framing the mind as a transient process and suggesting hypnosis accelerates psychotherapy and learning.
Key Arguments: Stage hypnosis is a performance that cherry-picks responsive volunteers; clinical hypnosis is a legitimate treatment tool grounded in research. Hypnosis is more than placebo and can meaningfully increase psychotherapy’s effect size. The strongest evidence base is for pain management, especially acute burn pain and chronic pain. Hypnosis can help anxiety, IBS, smoking cessation, and possibly weight loss, but it works best as part of a broader treatment plan. Most people are moderately hypnotizable; a small minority are highly responsive and a small minority barely respond at all. Hypnosis cannot make people commit murder or other antisocial acts against their will. People with strong dissociative tendencies or trauma histories require careful, structured hypnosis to avoid harm. Self-hypnosis can be useful, but guided hypnosis and repeated recorded practice are typically more effective. Post-hypnotic suggestions can be especially useful for procedures like surgery, childbirth, dentistry, and burn care. Remote hypnosis via Zoom is viable, though in-person sessions allow better attunement to breathing and body cues. Hypnosis and virtual reality are empirically distinct interventions; combining them has not yet produced a superior integrated method. The field’s public and academic visibility has waned, partly due to the rise of mindfulness, but research interest is resurging. There are parallels between advanced hypnosis and psychedelic therapy in the need for skilled guidance and safety. The central therapeutic value of hypnosis is to accelerate psychotherapy by improving focus, suggestion, and learning.
Data Points: University of Washington NIH-funded hypnosis studies: many studies over 30 years - Patterson describes his long research program funded by the NIH Published articles on hypnosis: more than 100 - He notes his publication record in peer-reviewed journals Highly responsive volunteers in stage hypnosis: about 5 out of 20 - Example of stage hypnotists selecting the most responsive people from a group People who do not respond well to hypnosis: about 10% - Patterson estimates the low-responsiveness tail of the hypnotizability curve Highly responsive people: 10% to 15% - Patterson estimates the high-responsiveness tail of the curve Typical hypnotizability distribution: bell-shaped curve - He characterizes responsiveness as distributed across the population with most in the middle Burn-care career milestone: 1989 - Year Patterson received his first NIH grant after his burn-unit hypnosis work Zoom-based hypnosis during the pandemic: 90% - Proportion of his hypnosis sessions he says were done over Zoom during COVID-19 Burn debridement suggestion protocol: 20 steps - He describes an induction where the patient was taken down 20 steps before post-hypnotic suggestion Progressive relaxation efficiency: 20-minute relaxation in 5 minutes - Patterson says hypnosis can compress a long relaxation routine into a shorter time Burn-care on shoulder cue: touch on the shoulder - Post-hypnotic cue used successfully during burn debridement FDA/health claim evidence areas: acute and chronic pain, IBS, anxiety, smoking cessation, weight loss - Conditions he identifies as supported by research to varying degrees
Pivotal Quotes: "Hypnosis is known to increase the effect size of psychotherapy by a large amount." — Dr. David Patterson: He explains why hypnosis is valuable clinically beyond being a standalone technique "You’re asking the wrong question because there’s a series of brain changes that happen." — Dr. David Patterson: His response to whether hypnosis is a distinct brain state "I think hypnosis has been hijacked by mindfulness." — Dr. David Patterson: He explains hypnosis’s reduced presence in graduate training and changing clinical fashions
Implications: Listeners should see hypnosis as a legitimate adjunct to evidence-based care, especially for pain and procedure-related distress. The field may grow again as neuroscience, remote care, mindfulness, and psychedelic-assisted therapy increase interest in brain-based treatments.